Exact Sciences Corporation - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Exact Sciences Corporation. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Exact Sciences Corporation. The Group's principal activities are to develop and commercialize proprietary DNA based tests for the early detection of cancer and other types of common cancers. PreGen-Plus utilizes PreGen technologies to isolate the minute amounts of human DNA shed from the colon into stool and then identifies mutations in DNA shed from abnormal cells indicative of colorectal cancer and pre-cancerous lesions. It also offers PreGen-Plus through LabCorp, in the United States with 35 primary laboratories and over 1,600 patient service centers. LabCorp is the exclusive licensee, in the United States and Canada, of the technology that surrounds PreGen-Plus.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report